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doi:10.1016/j.ejvs.2010.02.025Abstract Introduction: Digital photoplethysmography (PPG) provides an inexpensive, repro-
ducible, quantitative, non-invasive assessment of lower limb venous function.
Aim: To examine the relationship between venous refilling time (VRT) and severity of venous
disease, and also between changes in VRT and symptomatic improvement after ultrasound
guided foam sclerotherapy (UGFS) for symptomatic superficial venous reflux (SVR).
Methods: Prior to and 6 months after UGFS, 246 patients (317 limbs) completed a symptom
questionnaire, underwent duplex ultrasonography and clinical assessment, and VRT measure-
ment by digital PPG. Health related quality of life (HRQL) questionnaires were also completed.
Results: Median VRT improved from 11 to 31 s (P < 0.0005, Wilcoxon Signed Ranks). Abnormal
VRT (<20 s) correlated well with the presence of SVR on duplex (sensitivity 75%, specificity
94%). Pre-treatment there was a significant relationship between reducing VRT and increasing
CEAP clinical grade (P < 0.0005, c2), extent of SVR on duplex (P < 0.0005) and a non-significant
relationship with overall increasing symptom severity (P Z 0.097). Relief of all symptoms was
more likely when there was normalisation of VRT after treatment (80% vs. 65%, P < 0.0005, c2).
Pre-treatment VRT correlated with both generic physical (r Z 0.428, P Z 0.002) and disease-
specific (r Z 0.413, P Z 0.003, Spearman’s rank) HRQL.
Conclusions: UGFS for SVR improves VRT measured by digital PPG and that improvement corre-
lates with symptom relief.
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Although population based studies have reported a poor
correlation between lower limb symptoms and the pres-
ence and severity of lower limb venous disease,1,2
numerous groups, including our own, have shown that the
surgical treatment of superficial venous reflux (SVR)
improves symptoms, generic and disease-specific health
related quality of life (HRQL),3e7 as well as venous hae-
modynamics as measured by digital photoplethysmography
(PPG).8 However, outcomes following non-surgical treat-
ments for SVR, and the relationships between changes in
venous refilling time (VRT) and relief of physical symptoms,
are not well defined. The aim of the present study, there-
fore, was to examine for the first time the relationship
between VRT and severity of venous disease, and also the
relationship between changes in VRT and symptomatic
improvement after ultrasound guided foam sclerotherapy
(UGFS) for symptomatic SVR.
Methods
Local ethics committee approval and written informed
consent from each patient included in the study was
obtained. Prior to and 6 months after UGFS for symptomatic
isolated SVR, 246 consecutive patients (317 limbs)
completed a symptom questionnaire and underwent CEAP
grading,9 duplex ultrasonography (DUS), and measurement
of VRT by digital PPG. Limbs with deep venous reflux were
excluded. The asymptomatic, contralateral limbs of 47
patients were also examined. Patients undergoing unilat-
eral treatment also completed generic (SF12) and disease-
specific (Aberdeen Varicose Vein Symptom Severity Score
[AVSS]) HRQL questionnaires.
Duplex ultrasound examination
All examinations were performed in a standard manner by
one of the authors (GB). Patients were examined standing
with their weight on the contralateral limb and the leg to be
examined slightly bent with the heel on the floor to relax the
calf muscle while maintaining stability, with a Sonosite
Micromaxx (Sonosite Ltd, Hitchin, Herts, UK) using a 10MHz
transducer. The following venous segments were insonated:
proximal anddistal superficial femoral vein; aboveandbelow
knee popliteal vein; saphenofemoral and sapheno-popliteal
junctions, the whole length of the great saphenous vein
(GSV) and the small saphenous vein (SSV). All veins were
assessed for patency and compressibility. Refluxwas induced
with amanual calf squeezeandwasdefinedas reverseflowof
greater than 0.5 s. To grade the extent of reflux according to
duplex scanning, we determined the presence of reflux in 4
superficial venous segments: GSV in the thigh, GSV below the
knee, SSV, and anterior accessory saphenous vein (AASV),
giving a score of 0e4 refluxing venous segments.
Photoplethysmography
Quantitative digital PPG (Huntleigh Dopplex Vascular Assist,
Huntleigh Healthcare, UK) was used tomeasure post-exercise
VRT in the sitting position as previously described.10 The PPGprobe was attached to the skin using a double-sided sticky
pad, 10cm above the medial malleolus and 1e2 cm posterior
to the subcutaneous border of the tibia. Any areas of scarring,
prominent varicosities, or pigmentation were avoided. With
the patient remaining still, the computer automatically cali-
brated the signal, andonce a stable baselinewas achieved the
exercise was commenced using an inbuilt metronome.
Patients completed 10 dorsi- and plantar-flexions over a 15 s
period and were then asked to rest as motionless as possible.
The ejection of blood from the skin and the subsequent
refilling curve are displayed visually and the computer calcu-
lates the RT (seconds) fromthe curveup to amaximumof45 s.
VRTwas measured twice in each limb 2e5 min apart, and the
meanof the twomeasurements used. Normal VRTwas defined
as20 s. VRTmeasurementwas repeated ineach treated limb
6 months after UGFS.
Symptom questionnaire
Patients were asked to complete a symptom questionnaire
based upon the Edinburgh Vein Study1,2 one week before and
six months after UGFS treatment regarding the presence of
pain, itching, tingling, cramp, restless legs, feeling of
swelling and heaviness. Possible responses in terms of
symptom improvement were ‘‘none at all’’, ‘‘a little’’,
‘‘quite a bit’’, ‘‘a lot’’ and ‘‘an awful lot’’. For the purposes
of analysis, only ‘‘quite a bit’’, ‘‘a lot’’, and ‘‘an awful lot’’
were considered symptomatic improvement.
HRQL questionnaires
Patients undergoing unilateral UGFS completed generic
(Physical Component Summary score [PCS] of the Short
Form [SF]-12) and disease-specific (AVSS) HRQL instruments
before and six months after treatment.3,11e14 A lower PCS
signifies worse general physical HRQL and the mean PCS of
the general population is set at 50. A higher AVSS signifies
more symptomatic lower limb venous disease.
Treatment details
UGFS was performed on an outpatient basis using foam
prepared by the Tessari technique (two, 2 ml syringes
connected with a 3-way tap and a 5 m filter) and comprising
one part 3% sodium tetradecyl sulphate. Fibrovein, STD
Pharmaceuticals, Hereford, UK) and three parts air. Venous
trunks to be treated were marked with the patient in the
standing position, and these were cannulated directly
under ultrasound guidance with the patient supine.
Following UGFS, compression was applied to the treated
limb by means of Pehahaft (Hartmann, Germany) bandage
over Velband (Johnson & Johnson Medical, Ascot, Berk-
shire, UK) applied along the length of treated vein, held in
place with Medipore (3M) adhesive tape. A thigh-length
class II compression stocking was applied over the
bandaging. This remained in place for 10 days, after which
time the bandaging was removed and the class II stocking
worn for a further 14 days. Success of treatment was
reviewed at one month and further injections undertaken
as judged necessary. Around 10e15% of limbs require
a second treatment.
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Non-parametric methods within Statistical Package for the
Social Sciences (SPSS) version 17.0 (SPSS, Chicago, IL, USA)
were used. Chi-squared test was used to compare the
proportions of limbs with each symptom according to
whether VRT was normal or abnormal prior to treatment,
and also whether individual symptoms were more likely to
improve in those limbs in which VRT normalised after
treatment. Chi-squared test for trend was used to examine
the relationship between pre-treatment VRT and both CEAP
clinical grade and the extent of SVR measured by DUS.
ManneWhitney U test was used to examine the difference
in median VRT by clinical severity and also extent of SVR.
Wilcoxon signed ranks test was used to determine intra-
person improvement in VRT following UGFS. Spearman’s
rank correlation was used to assess the relationship
between VRT and SF12 PCS and AVSS, and also between the
change in these values between 0 and 6 months.
Results
Demographics, CEAP clinical grade, treatment data and the
numbers available for analysis in each part of the analysis
are shown in Table 1.
All limbs had primary venous disease (EP) in association
with superficial venous reflux only (AS) without obstruction
(PR). Reflux was not present in any of the 47 CEAP C0 and C1
limbs.
Relationship between VRT, duplex findings and
clinical severity
For all 364 examined limbs, the presence of SVR on duplex




- Patients 246 198
- Limbs 364 247
Age (y)
- median (range) 56 (19e86) 58 (22e86)
Male sex 95 (39) 81 (41)
CEAP clinical grade
- C0 35 () 0 (0)
- C1 12 () 0 (0)
- C2 191 (60) 140 (57)
- C3 34 (11) 25 (10)
- C4 63 (20) 56 (23)
- C5 15 (5) 14 (6)
- C6 14 (4) 12 (5)
Recurrent disease 77 (21) 53 (21)
GSV reflux 313 (86) 215 (87)
a Percentages shown for CEAP clinical grade, recurrent disease and
excluded).defined as normal (20 s) or abnormal (<20 s), to deter-
mine the sensitivity and specificity of digital PPG-derived
VRT in detecting SVR. Abnormal VRT correlated well with
the presence of SVR on duplex (sensitivity 75% [95% CI
70e80%], specificity 94% [95% CI 82e98%]). An abnormal
VRTwas 12.5 times more likely to be obtained in a limb with
reflux.
Fig. 1 shows the relationship between median VRT and
the clinical severity of disease as defined by CEAP clinical
grade. Prior to treatment there was a significant rela-
tionship between reducing (worse) median VRT and
increasing CEAP clinical grade (P < 0.0005, c2 trend test).
ManneWhitney U (MWU) test was also used to compare
median VRT excluding those asymptomatic (C0/C1) limbs
without reflux. Limbs were grouped according to whether
they were uncomplicated (C2 and C3; n Z 225) or had
skin complications of venous disease (C4, C5 and C6;
n Z 92). Median VRT was significantly worse (P < 0.0005,
MWU) in those limbs with complicated VV (median 9.0s,
interquartile range [IQR] 6.0e14.0 s) compared
with those with uncomplicated VV (median 15.0s, IQR
9.0e23.8 s).
Fig. 2 shows the relationship between median VRT and
extent of SVR defined by the number of refluxing segments
seen on DUS in all 364 examined limbs. Prior to treatment
there was a significant relationship between reducing VRT
and the extent of SVR on DUS (P < 0.0005, c2 trend test).
MWU test was also used to compare the median VRT
excluding those asymptomatic (C0/C1) limbs without
reflux. Limbs were grouped according to whether they had
1e2 (n Z 300) or 3e4 (n Z 17) refluxing segments. There
was no difference in median VRT between the two groups;
median VRT 12.0 s in both groups.
Data on lower limb symptoms and pre-treatment VRT
was available for 247 limbs. The number of lower limb






60 (29e86) 58 (29e79)
24 (29) 20 (40)
0 (0) 0 (0)
0 (0) 0 (0)
50 (50) 24 (48)
18 (18) 8 (16)
21 (21) 10 (20)
5 (5) 4 (8)
7 (7) 4 (8)
20 (20) 7 (14)
83 (82) 38 (76)
GSV reflux are for 317 symptomatic limbs only (C0 and C1 limbs
P < .0005
Figure 1 Box and whisker plot indicating venous refilling
time (VRT) by CEAP clinical grade. The horizontal line inside
each box indicates the median; the box itself represents the
interquartile range (IQR). Dots represent outliers which are
observations lying more than 1.5 times the IQR from the first or
third quartile. Asterisks represent extremes which are values
more than 3 times the IQR above or below the third or first
quartile respectively. Whiskers represent the largest and
smallest values that are not outliers or extremes. P value from
Chi-squared test for trend.
Figure 3 Bar chart showing the prevalence of each lower
limb symptom according to venous refilling time. Sixty limbs
had VRT 20 s; 187 limbs had VRT <20 s.
270 K.A.L. Darvall et al.the VRT in that limb was normal or abnormal. An abnormal
VRT became more common as the number of symptoms
present increased: 28 of 41 limbs (68%) with 1 or 2 symp-
toms only had an abnormal VRT, compared to 45 of 54 limbs
(83%) with all 7 symptoms, but this did not reach statistical
significance (P Z 0.097, c2 trend test).
The percentage of limbs with each symptom according
to normal or abnormal VRT is shown in Fig. 3. Only itching
(74% vs. 60%, P Z 0.034, c2 test) and a feeling of swelling
(75% vs. 45%, P < 0.0005, c2 test) were significantly more
common in limbs with abnormal VRT.P < .0005 
Figure 2 Box and whisker plot indicating venous refilling
time (VRT) by the number of refluxing segments present on
duplex scanning.Relationship between improvements in VRT and
symptoms after UGFS
There was a significant improvement in median (IQR) VRT
after UGFS (n Z 101, median 11 [8e18] vs. 31 [20e44]
seconds, P < 0.0005, Wilcoxon signed ranks test).
Limbs that showedno change in VRT (abnormal, nZ 23, or
normal, nZ 17, pre- and post-treatment) are comparedwith
those that normalised their VRT in Fig. 4. Relief of all symp-
toms was significantly more likely when there was normal-
isation of a previously abnormal VRT (80% vs. 65%, P< 0.0005,
c2 test). Each lower limb symptom showed more improve-
ment in the limbs that also showed improvement in VRT from
abnormal to normal. Looking at individual symptoms, this
attained statistical significance for itching (87% vs. 64%,
P Z 0.021, c2 test), but not for pain (P Z 0.54), tingling
(PZ 0.13), cramp (PZ 0.18), restless legs (PZ 0.16), feeling
of swelling (PZ 0.28), or heaviness (PZ 0.062).
Relationship between improvements in VRT and
HRQL
In the subgroup of 50 patients who also completed HRQL
questionnaires (SF12 and AVSS), pre-treatment VRT showed
significantcorrelationwithbothSF12PCS (rZ0.43,PZ0.002,Figure 4 Bar chart showing the proportion of limbs in which
improvement in lower limb symptoms was seen following
treatment according to measured improvement in venous
refilling time (VRT).
r = .428 
P = .002 
Figure 5 Correlation between pre-treatment venous refilling
time (VRT) and pre-treatment Physical Component Summary
score (PCS) of the SF12. r and P values from Spearman’s rank
correlation.
Improvement in VRT After Foam Sclerotherapy 271Spearman’s rank)andAVSS (rZ0.41,PZ 0.003, Spearman’s
rank) (Figs. 5and6).The samerelationshipswerepresentafter
6 months but the association was weaker and did not reach
significance (PCS: r Z 0.28, P Z 0.05; AVSS: r Z 0.19,
P Z 0.18; Spearman’s rank). There was no significant corre-
lation between change in VRT between 0 and 6 months, and
change in either PCS or AVSS between 0 and 6 months.
Discussion
The main findings of the current study are that VRT
measured by digital PPG correlates well with clinical
severity of venous disease, and also with lower limb
symptoms and HRQL. However, patients in CEAP clinical
stages C3eC6 showed similar venous refilling times. VRT
improved significantly following UGFS and was associated
with an improvement in lower limb symptoms, particularly
itching and heaviness.r = -.413 
P = .003 
Figure 6 Correlation between pre-treatment venous refilling
time (VRT) and pre-treatment Aberdeen Varicose Vein score
(AVSS). r and P values from Spearman’s rank correlation.Direct ambulatory venous pressure (AVP) measurement
is believed to give the best overall assessment of lower limb
venous function, but it is invasive and thus unsuitable for
routine clinical use.15 Air plethysmography gives accurate
and reproducible information and is non-invasive but the
test is time-consuming and relies on bulky equipment.16
VRT measured by PPG correlates well with direct pressure
measurements.17e19
Kulkarni et al. found significant improvements in median
VRT in patients undergoing superficial venous surgery as
part of their treatment for chronic venous ulceration (CEAP
C5 or 6).8 Interestingly, they also found that the patients
who had ulcer recurrence had no such improvement in VRT,
concluding that a low VRT after surgery predicts ulcer
recurrence.8 The measurement of VRT using a tourniquet
has previously been shown to predict haemodynamic
improvement after saphenous surgery,20 and Gohel et al.
found the same to be true for healing rates and recurrence
rates of chronic venous ulceration in patients undergoing
superficial venous surgery.21
The current study provides evidence that the significant
improvement in VRT observed after UGFS also translates to
an improvement in lower limb venous symptoms. This lends
some support to the suggestion by Beraldo et al. that PPG be
used as an initial screening test to give objective evidence of
venous dysfunction and thus identify those most likely to
benefit from intervention.22 Thus, we have found that limbs
with a normal VRT prior to treatment are less likely to have
symptoms, and that those symptoms are less likely to
improve following treatment. The poor response rate to the
HRQL questionnaires and repeat VRT measurements at
6 months is a weakness of the study. Unilateral procedures
were performed in 128 patients, yet complete data were
available for only 50. However, it can be seen in Table 1 that
these 50 differed little in terms of demographics, CEAP
clinical grade and treatment data from the whole cohort.
In conclusion, VRT measured by digital PPG is a simple,
non-invasive and reproducible test of venous function that
correlates well with clinical severity of venous disease and
helps predict symptomatic improvement following inter-
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